| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigation |
1 Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel; 2 Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel; 3 Deparment of Diagnostic Radiology, Rambam Medical Center, Haifa, Israel; and 4 Department of Vascular Surgery, Rambam Medical Center, Haifa, Israel
Correspondence: For correspondence or reprints contact: Rachel Bar-Shalom, MD, Department of Nuclear Medicine, Rambam Medical Center, Haifa 35254, Israel. E-mail: r_bar_shalom{at}rambam.health.gov.il
The present study evaluated the role of SPECT/CT as an adjunct to 67Ga (GS) or 111In-labeled white blood cell (WBC) scintigraphy for diagnosis or localization of infection. Methods: Eighty-two patients (56 male and 26 female; mean age, 62 y) assessed for known or suspected infectious processes underwent 88 SPECT/CT studies. Forty-seven patients underwent GS SPECT/CT (13 with fever of unknown origin, 21 with suspected osteomyelitis, and 13 with suspected soft-tissue infection), and 35 patients underwent WBC SPECT/CT (24 with suspected vascular graft infection, and 11 with suspected osteomyelitis). Ninety-eight suggestive sites were identified (52 on GS and 46 on WBC). Additional information provided by SPECT/CT for diagnosis or localization of infection, as compared with planar and SPECT scintigraphy, was recorded. The SPECT/CT contribution was analyzed on a patient and site basis and was compared for the 2 tracers and clinical indications. Results: SPECT/CT provided additional information for infection diagnosis and localization in 39 (48%) of 82 patients and in 47 (48%) of 98 sites. SPECT/CT defined the extent of infection in 35 patients (43%) in 43 sites (44%) and excluded infection in 4 suggestive sites defined as physiologic bowel uptake on GS. SPECT/CT was incorrect in 2 suggestive sites (1 GS and 1 WBC). The contribution of SPECT/CT was significantly higher for WBC than for GS (P < 0.05)—in 63% versus 36% of patients, respectively, and in 61% versus 36% of sites, respectively. Conclusion: SPECT/CT made an incremental contribution to GS and WBC in 48% of patients with suspected infections, by improving diagnosis, localization, and definition of extent of disease. SPECT/CT has an important role mainly with highly specific, low-background infection-seeking tracers such as WBC.
Key Words: SPECT/CT • gallium scintigraphy • labeled leukocyte scintigraphy • infection
Related articles in JNM:
This article has been cited by other articles:
|
|
 |
|
  A. K. Buck, S. Nekolla, S. Ziegler, A. Beer, B. J. Krause, K. Herrmann, K. Scheidhauer, H.-J. Wester, E. J. Rummeny, M. Schwaiger, et al. SPECT/CT J. Nucl. Med., August 1, 2008; 49(8): 1305 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bybel, R. C. Brunken, F. P. DiFilippo, D. R. Neumann, G. Wu, and M. D. Cerqueira SPECT/CT Imaging: Clinical Utility of an Emerging Technology RadioGraphics, July 1, 2008; 28(4): 1097 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Strobel, C. Burger, B. Seifert, D. B. Husarik, J. D. Soyka, and T. F. Hany Characterization of Focal Bone Lesions in the Axial Skeleton: Performance of Planar Bone Scintigraphy Compared with SPECT and SPECT Fused with CT Am. J. Roentgenol., May 1, 2007; 188(5): W467 - W474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Filippi and O. Schillaci Usefulness of Hybrid SPECT/CT in 99mTc-HMPAO-Labeled Leukocyte Scintigraphy for Bone and Joint Infections J. Nucl. Med., December 1, 2006; 47(12): 1908 - 1913. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
